Wagner Wealth Management (South Carolina)’s Haemonetics HAE Stock Holding History

Wagner Wealth Management (South Carolina)’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-28	Closed	-$2K	–	452
2022 Q3	$2K	Hold	28	–	–	﹤0.01%	608
2022 Q2	$2K	Buy	+28	New	+$1.66K	﹤0.01%	618
2022 Q1	–	Sell	-28	Closed	-$1K	–	404
2021 Q4	$1K	Hold	28	–	–	﹤0.01%	658
2021 Q3	$2K	Hold	28	–	–	﹤0.01%	600
2021 Q2	$2K	Hold	28	–	–	﹤0.01%	631
2021 Q1	$3K	Buy	+28	New	+$3.46K	﹤0.01%	584
2018 Q3	$15K	Hold	131	–	–	0.01%	376
2018 Q2	$12K	Hold	131	–	–	0.01%	375
2018 Q1	$10K	Buy	131 +28	+27%	+$1.92K	0.01%	371
2017 Q4	$10K	Buy	+103	New	+$5.42K	0.01%	408

Other funds holding HAE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Wagner Wealth Management (South Carolina)'s HAE Position: Q4 2022 in Review

Wagner Wealth Management (South Carolina) sold out of Haemonetics (HAE) in Q4 2022, closing a stake of 28 shares — an estimated $2K sold.

Wagner Wealth Management (South Carolina) first reported a position in HAE in Q4 2017 and held it in 10 quarters. The position peaked at $15K in Q3 2018. 294 funds tracked by Wall St. Rank hold HAE as of Q4 2022.

Wagner Wealth Management (South Carolina) reported no remaining Haemonetics position as of Q4 2022 after selling out during the quarter.
Wagner Wealth Management (South Carolina) sold 28 Haemonetics shares in Q4 2022, an estimated $2K.
Wagner Wealth Management (South Carolina) first reported a position in Haemonetics in Q4 2017 and held it in 10 quarters.
Wagner Wealth Management (South Carolina)'s Haemonetics position peaked at $15K in Q3 2018.
294 funds tracked by Wall St. Rank held Haemonetics as of Q4 2022.

Based on Wagner Wealth Management (South Carolina)'s 13F filing for Q4 2022, filed 14 Feb 2023.